GGrantIndex
Sort

16,300 grants matching fatty liver disease

Targeting ethanol-induced gut dysbiosis with synbiotics to treat alcoholic liver

$249,000
Gail Ann Cresci · Cleveland Clinic Lerner Com-Cwru · R00 · FY2019 · AA

The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes

$249,000
Zhao Zhang · Ut Southwestern Medical Center · R00 · FY2022 · DK

Does SIRT1 regulate mammalian health and longevity?

$249,000
Joseph A. Baur · University Of Pennsylvania · R00 · FY2009 · AG

Coordination of energy metabolism across individual tissues in mammals

$249,000
Sheng Hui · Harvard School Of Public Health · R00 · FY2020 · DK

Synergy of lipolysis and lipophagy in alcoholic liver disease

$249,000
Micah Schott · University Of Nebraska Medical Center · R00 · FY2021 · AA

Protective effects of amlexanox against atherosclerosis

$249,000
Peng Zhao · University Of Texas Hlth Science Center · R00 · FY2023 · HL

Prenatal diet-stress interactions and the maternal metabolic response in human pregnancy

$249,000
Karen Lindsay · University Of California-Irvine · R00 · FY2020 · HD

The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes

$249,000
Zhao Zhang · Ut Southwestern Medical Center · R00 · FY2020 · DK

Dissecting Sex-Specific Metabolic Responses to Inflammation

$249,000
Joni Nikkanen · University Of California Berkeley · R00 · FY2024 · DK

Liver fibrosis and ethanol: role of the transcription factor, Egr-1

$249,000
Michele T Pritchard · Case Western Reserve University · R00 · FY2011 · AA

The in vivo regulation of glucose homeostasis and lifespan by mTORC2

$249,000
Dudley William Lamming · University Of Wisconsin-Madison · R00 · FY2014 · AG

MerTK in NASH-related liver fibrosis

$249,000
Bishuang Cai · Icahn School Of Medicine At Mount Sinai · R00 · FY2020 · DK

The Role of KBTBD2 in Lipodystrophy, Insulin Resistance, and Diabetes

$249,000
Zhao Zhang · Ut Southwestern Medical Center · R00 · FY2021 · DK

Protective effects of amlexanox against atherosclerosis

$249,000
Peng Zhao · University Of Texas Hlth Science Center · R00 · FY2022 · HL

Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant States

$249,000
Ji Miao · Boston Children'S Hospital · R00 · FY2016 · DK

Protective effects of amlexanox against atherosclerosis

$249,000
Peng Zhao · University Of Texas Hlth Science Center · R00 · FY2021 · HL

Systems Genetics Analysis of Gene-by-Environment Interactions in Obesity

$249,000
Brian Wesley Parks · University Of Wisconsin-Madison · R00 · FY2016 · HL

Mechanisms of glycine-based therapy for atherosclerosis

$249,000
Oren Shalom Rom · Louisiana State Univ Hsc Shreveport · R00 · FY2023 · HL

Peroxisomal fatty acid metabolism in genetic and age-related disorders

$249,000
Meghna Gupta · Oregon Health & Science University · R00 · FY2024 · AG

Dietary factors, biomarkers, metabolic pathways related to non-alcoholic fatty liver disease

$249,000
Jiantao Ma · Tufts University Boston · K22 · FY2019 · HL

Investigating the role of AAA+-ATPases in peroxisome biology

$249,000
Brooke Meghan Gardner · University Of California Santa Barbara · R00 · FY2020 · GM

Targeting ethanol-induced gut dysbiosis with synbiotics to treat alcoholic liver

$249,000
Gail Ann Cresci · Cleveland Clinic Lerner Com-Cwru · R00 · FY2017 · AA

Lipid peroxidation-induced chemical modifications of insulin signaling proteins

$249,000
Krisztian Stadler · Lsu Pennington Biomedical Research Ctr · R00 · FY2010 · DK

Role of FoxO1 in Lipid Metabolism

$249,000
Rebecca Anne Haeusler · Columbia University Health Sciences · R00 · FY2016 · HL

Molecular Basis of Insulin Resistance

$249,000
Maureen J Charron · Albert Einstein College Of Medicine · R21 · FY2008 · DK